<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35170853</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-1716</ISSN><JournalIssue CitedMedium="Internet"><Volume>234</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta physiologica (Oxford, England)</Title><ISOAbbreviation>Acta Physiol (Oxf)</ISOAbbreviation></Journal><ArticleTitle>Modulation of spinal inhibition in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e13801</StartPage><MedlinePgn>e13801</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/apha.13801</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swash</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8717-8914</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Barts and the London School of Medicine, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neuroscience (Physiology), University of Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Physiol (Oxf)</MedlineTA><NlmUniqueID>101262545</NlmUniqueID><ISSNLinking>1748-1708</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Acta Physiol (Oxf). 2022 Apr;234(4):e13758</RefSource><PMID Version="1">34981890</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35170853</ArticleId><ArticleId IdType="doi">10.1111/apha.13801</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Sangari S, Peyre I, Lackmy-Vall&#xe9;e A, Bayen E, Pradat P-F, Marchand-Pauvert V. Transient increase in recurrent inhibition in amyotrophic lateral sclerosis as a putative protection from neurodegeneration. Acta Physiol. 2022;23:e13758.</Citation></Reference><Reference><Citation>Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry. 1970;33:338-357.</Citation></Reference><Reference><Citation>Gromicho M, Figueiral, Uysal UH, et al. Spreading in amyotrophic lateral sclerosis: the relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol. 2020;2:1181-1192.</Citation></Reference><Reference><Citation>Ravits JM, La Spada AR. Amyotrophic lateral sclerosis motor phenotype heterogeneity, focality and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805-811. doi:10.1212/WNL.0b013e3181b6bbbd</Citation></Reference><Reference><Citation>Swash M, Fox KP. The pathology of the muscle spindle: effect of denervation. J Neurol Sci. 1974;22:1-24.</Citation></Reference><Reference><Citation>Stephens B, Guiloff RJ, Navarotte R, et al. Widespread loss of neuronal populations in the spinal ventral horn in amyotrophic lateral sclerosis: a morphometric study. J Neurol Sci. 2006;244:41-58.</Citation></Reference><Reference><Citation>Chen H, Kankel MW, Su SC, et al. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTD. Cell Death Differ. 2018;25:648-662.</Citation></Reference><Reference><Citation>Eisen A, Braak H, Del Tredici K, et al. Cortical influences drive amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:917-924.</Citation></Reference><Reference><Citation>Hultborn H, Brownstone RS, Toth H, et al. Key mechanisms for setting the input-output gain across the motor neuron pool. Prog Brain Res. 2004;143:77-95.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>